Reactive oxygen metabolites cause massive, reversible proteinuria and glomerular sieving defect without apparent ultrastructural abnormality. Yoshioka T, Ichikawa I, Fogo A (1991) J Am Soc Nephrol 2: 902-12 Elevated plasma and urinary guanosine 3':5'-monophosphate and increased production rate in patients with neoplastic diseases. Chawla RK, Shlaer SM, Lawson DH, Murray TG, Schmidt F, Shoji M, Nixon DW, Richmond A, Rudman D (1980) Cancer Res 40: 3915-20 Role for "uremic toxin" in the progressive loss of intact nephrons in chronic renal failure. Motojima M, Nishijima F, Ikoma M, Kawamura T, Yoshioka T, Fogo AB, Sakai T, Ichikawa I (1991) Kidney Int 40: 461-9 Partial gene deletion of endothelial nitric oxide synthase predisposes to exaggerated high-fat diet-induced insulin resistance and arterial hypertension. Cook S, Hugli O, Egli M, Ménard B, Thalmann S, Sartori C, Perrin C, Nicod P, Thorens B, Vollenweider P, Scherrer U, Burcelin R (2004) Diabetes 53: 2067-72 Inhalation of insulin in dogs: assessment of insulin levels and comparison to subcutaneous injection. Cherrington AD, Neal DW, Edgerton DS, Glass D, Bowen L, Hobbs CH, Leach C, Rosskamp R, Strack TR (2004) Diabetes 53: 877-81 Kinetic analysis of nanoparticulate polyelectrolyte complex interactions with endothelial cells. Hartig SM, Greene RR, Carlesso G, Higginbotham JN, Khan WN, Prokop A, Davidson JM (2007) Biomaterials 28: 3843-55 Vigorous motor activity in Caenorhabditis elegans requires efficient clearance of dopamine mediated by synaptic localization of the dopamine transporter DAT-1. McDonald PW, Hardie SL, Jessen TN, Carvelli L, Matthies DS, Blakely RD (2007) J Neurosci 27: 14216-27 Caffeine attenuates the renal vascular response to angiotensin II infusion. Brown NJ, Ryder D, Nadeau J (1993) Hypertension 22: 847-52 Vancomycin pharmacokinetics, renal handling, and nonrenal clearances in normal human subjects. Golper TA, Noonan HM, Elzinga L, Gilbert D, Brummett R, Anderson JL, Bennett WM (1988) Clin Pharmacol Ther 43: 565-70 Retrieval of renal function by revascularization. Study of preoperative outcome predictors. Dean RH, Englund R, Dupont WD, Meacham PW, Plummer WD, Pierce R, Ezell C (1985) Ann Surg 202: 367-75 Defective glucose utilization in patients with functioning beta-cell tumors persists after tumor excision. McGee GS, Kulaylat MM, Abumrad NN (1987) Ann Surg 206: 449-57 Associations between CYP2B6 polymorphisms and pharmacokinetics after a single dose of nevirapine or efavirenz in African americans. Haas DW, Gebretsadik T, Mayo G, Menon UN, Acosta EP, Shintani A, Floyd M, Stein CM, Wilkinson GR (2009) J Infect Dis 199: 872-80 Clinical and genetic determinants of plasma nevirapine exposure following an intrapartum dose to prevent mother-to-child HIV transmission. Vardhanabhuti S, Acosta EP, Ribaudo HJ, Severe P, Lalloo U, Kumarasamy N, Taulo F, Kabanda J, Oneko O, Ive P, Sambarey P, Chan ES, Hitti J, Hong F, McMahon D, Haas DW, A5207 ACTG Study Team (2013) J Infect Dis 208: 662-71 Pharmacokinetics and pharmacodynamics of imipenem and meropenem in critically ill patients treated with continuous venovenous hemodialysis. Afshartous D, Bauer SR, Connor MJ, Aduroja OA, Amde M, Salem C, Groszek JJ, Fissell WH (2014) Am J Kidney Dis 63: 170-1 Cefazolin as empiric therapy in hemodialysis-related infections: efficacy and blood concentrations. Marx MA, Frye RF, Matzke GR, Golper TA (1998) Am J Kidney Dis 32: 410-4 Safety, pharmacokinetics and pharmacodynamics of the anti-A33 fully-human monoclonal antibody, KRN330, in patients with advanced colorectal cancer. Infante JR, Bendell JC, Goff LW, Jones SF, Chan E, Sudo T, Burris HA, Berlin JD (2013) Eur J Cancer 49: 1169-75 Effects of antacids and dialysate dwell times on multiple-dose pharmacokinetics of oral ciprofloxacin in patients on continuous ambulatory peritoneal dialysis. Golper TA, Hartstein AI, Morthland VH, Christensen JM (1987) Antimicrob Agents Chemother 31: 1787-90 Lung tumor resection does not affect debrisoquine metabolism. Shaw GL, Falk RT, Deslauriers J, Nesbitt JC, McKneally MF, Frame JN, Feld R, Issaq HJ, Ruckdeschel JC, Hoover RN (1994) Cancer Epidemiol Biomarkers Prev 3: 141-4 Heart-type fatty acid-binding protein reciprocally regulates glucose and fatty acid utilization during exercise. Shearer J, Fueger PT, Rottman JN, Bracy DP, Binas B, Wasserman DH (2005) Am J Physiol Endocrinol Metab 288: E292-7 Insulin-independent effects of GLP-1 on canine liver glucose metabolism: duration of infusion and involvement of hepatoportal region. Dardevet D, Moore MC, Neal D, DiCostanzo CA, Snead W, Cherrington AD (2004) Am J Physiol Endocrinol Metab 287: E75-81 Determination of the lower threshold of apolipoprotein E resulting in remnant lipoprotein clearance. Hasty AH, Linton MF, Swift LL, Fazio S (1999) J Lipid Res 40: 1529-38 Control of muscle glucose uptake: test of the rate-limiting step paradigm in conscious, unrestrained mice. Fueger PT, Shearer J, Bracy DP, Posey KA, Pencek RR, McGuinness OP, Wasserman DH (2005) J Physiol 562: 925-35 Breast cancer resistance protein (ABCG2) and drug disposition: intestinal expression, polymorphisms and sulfasalazine as an in vivo probe. Urquhart BL, Ware JA, Tirona RG, Ho RH, Leake BF, Schwarz UI, Zaher H, Palandra J, Gregor JC, Dresser GK, Kim RB (2008) Pharmacogenet Genomics 18: 439-48 The role of aldehyde oxidase and xanthine oxidase in the biotransformation of a novel negative allosteric modulator of metabotropic glutamate receptor subtype 5. Morrison RD, Blobaum AL, Byers FW, Santomango TS, Bridges TM, Stec D, Brewer KA, Sanchez-Ponce R, Corlew MM, Rush R, Felts AS, Manka J, Bates BS, Venable DF, Rodriguez AL, Jones CK, Niswender CM, Conn PJ, Lindsley CW, Emmitte KA, Daniels JS (2012) Drug Metab Dispos 40: 1834-45 Chronic estradiol and progesterone treatment in conscious dogs: effects on insulin sensitivity and response to hypoglycemia. Batista MR, Smith MS, Snead WL, Connolly CC, Lacy DB, Moore MC (2005) Am J Physiol Regul Integr Comp Physiol 289: R1064-73 Relationship between the plasma glucose level and glucose uptake in the conscious dog. Cherrington AD, Williams PE, Harris MS (1978) Metabolism 27: 787-91 Pharmacokinetics of O6-benzylguanine (NSC637037) and its metabolite, 8-oxo-O6-benzylguanine. Tserng KY, Ingalls ST, Boczko EM, Spiro TP, Li X, Majka S, Gerson SL, Willson JK, Hoppel CL (2003) J Clin Pharmacol 43: 881-93 The effect of tobramycin on the renal handling of vancomycin. Munar MY, Elzinga L, Brummett R, Golper TA, Bennett WM (1991) J Clin Pharmacol 31: 618-23 Novel dialysis modalities: do we need new metrics to optimize treatment? Fissell R, Schulman G, Pfister M, Zhang L, Hung AM (2012) J Clin Pharmacol 52: 72S-8S Lack of effect of aprepitant on the pharmacokinetics of docetaxel in cancer patients. Nygren P, Hande K, Petty KJ, Fedgchin M, van Dyck K, Majumdar A, Panebianco D, de Smet M, Ahmed T, Murphy MG, Gottesdiener KM, Cocquyt V, van Belle S (2005) Cancer Chemother Pharmacol 55: 609-16 The effect of cimetidine on cyclophosphamide metabolism in rabbits. Anthony LB, Long QC, Struck RF, Hande KR (1990) Cancer Chemother Pharmacol 27: 125-30 Steady-state pharmacokinetics and tolerability of indinavir-lopinavir/r combination therapy in antiretroviral-experienced patients. Antoniou T, Tseng AL, van Heeswijk RP, Walker SE, Giguere P, Phillips EJ (2005) Ther Drug Monit 27: 779-81 The relationship between plasma concentration and disappearance rate of immunoreactive insulin in the conscious dog. Stevenson RW, Cherrington AD, Steiner KE (1985) Horm Metab Res 17: 551-3 Antimicrobial dosing in acute renal replacement. Fissell WH (2013) Adv Chronic Kidney Dis 20: 85-93 Drug removal during continuous arteriovenous hemofiltration: theory and clinical observations. Golper TA, Wedel SK, Kaplan AA, Saad AM, Donta ST, Paganini EP (1985) Int J Artif Organs 8: 307-12 Biologic comparison of inhaled insulin formulations: Exubera™ and novel spray-dried engineered particles of dextran-10. Kuehl PJ, Cherrington A, Dobry DE, Edgerton D, Friesen DT, Hobbs C, Leach CL, Murri B, Neal D, Lyon DK, Vodak DT, Reed MD (2014) AAPS PharmSciTech 15: 1545-50 Are both creatinine and urea clearances necessary as indices of small solute clearance adequacy in peritoneal dialysis? Tzamaloukas AH, Golper TA (2000) ASAIO J 46: 651-3
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.